Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis

Journal of Biotechnology

Volumn 44, Issue 1-3, 1996, Pages 97-103

  Dmitriev, Igor P ^a   Khromykh, Alexander A ^a,b   Ignatyev, George M ^a   Gainullina, Margarita N ^a   Ageenko, Valentina A ^a   Dryga, Sergey A ^a   Vorobyeva, Maya S ^c   Sandakhchiev, Lev S ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Tarasevic State Institute for the Standardization and Control of Medical Biological Preparations   (France)

Author keywords

Protectivity; Recombinant vaccinia virus; Tick borne encephalitis virus; Vaccine candidate

Indexed keywords

ANTIBODIES; DNA; GENETIC ENGINEERING; LIVING SYSTEMS STUDIES; VACCINES; VIRUSES;

RECOMBINANT VACCINIA VIRUS; TICK BORNE ENCEPHALITIS VIRUS;

IMMUNIZATION;

COMPLEMENTARY DNA; RECOMBINANT VACCINE; TICK BORNE ENCEPHALITIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; ENCEPHALITIS; IMMUNE RESPONSE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINATION; VACCINIA VIRUS;

EID: 0030044237     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(95)00141-7     Document Type: Conference Paper

References (29)

1. Amberg, S.M., Nestorowicz, A., McCourt, D.W. and Rice, C.M. (1994) NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: In vitro and in vivo studies. J. Virol. 68, 3794-3802.
2. Chambers, T.J., Hahn, C.S., Galler, R. and Rice, C.M. (1990) Flavivirus genome organization, expression and replication. Annu. Rev. Microbiol. 44, 649-688.
3. Deubel, V., Kinney, R.M., Espozito, J.J., Cropp, C.B., Vorndam, A.V., Monath, T.P. and Trent, D.W. (1988) Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J. Gen. Virol. 69, 1921-1929.
4. Hahn, Y.S., Lenches, E.M., Galler, R., Rice, C.M., Dalrymple, J. and Srauss, J.H. (1990) Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses. Arch. Virol. 115, 251-265.
5. Joklik, W.K. (1962) The purification of four strains of poxvirus. Virology 18, 9-18.
6. Konishi, E., Pincus, S., Paoletti, E., Shope, R.E., Burrage, T. and Mason, P.W. (1992a) Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188, 714-720.
7. Konishi, E., Pincus, S., Paoletti, E., Laegreid, W.W., Shope, R.E. and Mason, P.W. (1992b) A highly attenuated host range restricted vaccinia virus strain, NYVAC, encoding the prM, E and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 190, 454-458.
8. Konishi, E., Pincus, S., Paoletti, E., Shope, R.E. and Mason, P.W. (1994) Avipox virus vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 12, 33-638.
9. Kozak, M. (1989)The scanning model for translation: an update. J. Cell Biol. 108, 229-241.
10. Kurane, I., Brinton, M.A., Samson, A.L. and Ennis, F.A. (1991) Dengue virus-specific, human CD4+CD8-cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65, 1823-1828.
11. Lobigs, M., Arthur, C.E., Mullbacher, A. and Blanden, R.V. (1994) The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 202, 195-201.
12. Mandl, C.W., Heinz, F.X., Stockl, E. and Kunz, C. (1989) Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology 173, 291-301.
13. Mason, P.W., Pincus, S., Fournier, M.J., Mason, T.L., Shope, R.E. and Paoletti, E. (1991) Japanese encephalitis virus vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180, 294-305.
14. Nowak, T., Farber, P.M., Wengler, G. and Wengler, G. (1989) Analyses of the terminal sequences of West Nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis. Virology 169, 365-376.
15. Pincus, S., Mason, P.W., Konishi, E., Fonseca, B.A., Shope, R.E., Rice, C.M. and Paoletti, E. (1992) Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 187, 290-297.
16. Parrish, C.R., Coi, G., Hill, A., Mullbacher, A., Westaway, E.G. and Blanden R.V. (1991) Preliminary analysis of murine cytotoxic T cell responses to the proteins of the flavivirus Kunjin using vaccinia virus expression. J. Gen. Virol. 72, 1645-1653.
17. Pletnev, A.G., Yamshchikov, V.F. and Blinov, V.M. (1990) Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus. Virology 174, 250-263.
18. Putnak, R. (1994) Progress in the development of recombinant vaccines against dengue and other arthropodborne flaviviruses. In: Kurstak, E. (Ed), Modern Vaccinology, Plenum Publishing Corporation, New York, pp. 231-252.
19. Reed, L.J. and Muench, H. (1938) A simple method of estimating fifty percent endpoints. Am. J. Hyg. 37, 493-497.
20. Safronov, P.F., Netesov, S.V., Mikriukova, T.P., Blinov, V.M., Osipova, E.G., Kiseleva, N.N. and Sandakhchiev, L.S. (1991) Nucleotide sequence of genes and complete amino acid sequence of tick-borne encephalitis virus strain 205. Mol. Gen. Mikrobiol. Virusol. (Russia) 4, 23-29.
21. Sato, T., Takamura, C., Yasuda, A., Miyamoto, M., Kamogawa, K. and Yasui, K. (1993) High level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product. Virology 192, 483-490.
22. Shiu, S.Y., Reid, H.W. and Gould, E.A. (1992) Louping ill virus envelope protein expressed by recombinant baculovirus and vaccinia virus fails to stimulate protective immunity. Virus Res. 26, 213-229.
23. Smith, G.L., Mackett, M. and Moss, B. (1983) Infectious vaccinia virus recombinant that express hepatitis B virus surface antigen. Nature 302, 490-495.
24. Stephenson, J.R. (1988) Flavivirus vaccines. Vaccine 6, 471-480.
25. Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
26. Venugopal, K. and Gould, E.A. (1994) Towards a new generation of flavivirus vaccines. Vaccine 12, 966-975.
27. Yamshchikov, V.F. and Compans, R.W. (1993) Regulation of the late events in flavivirus protein processing and maturation. Virology 192, 38-51.
28. Yamshchikov, V.F. and Compans, R.W. (1994) Processing of the intracellular form of the west nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study. J. Virol. 68, 5765-5771.
29. Yasuda, A., Kuroda, K.J., Ogimoto, M., Miyamoto, M., Sata, T., Sato, T., Takamura, C., Kurata, T., Kojima, A. and Yasui, K. (1990) Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J. Virol. 64, 2788-2795.